| Literature DB >> 29436146 |
Yuri A Zarate1, Constance L Smith-Hicks2, Carol Greene3, Mary-Alice Abbott4, Victoria M Siu5, Amy R U L Calhoun6, Arti Pandya7, Chumei Li8, Elizabeth A Sellars1, Julie Kaylor9, Katherine Bosanko1, Louisa Kalsner10, Alice Basinger11, Anne M Slavotinek12, Hazel Perry12, Margarita Saenz13, Marta Szybowska8, Louise C Wilson14, Ajith Kumar14, Caroline Brain15, Meena Balasubramanian16, Holly Dubbs17, Xilma R Ortiz-Gonzalez17, Elaine Zackai17, Quinn Stein18, Cynthia M Powell7, Samantha Schrier Vergano19, Allison Britt20, Angela Sun21,22, Wendy Smith23, E Martina Bebin24, Jonathan Picker25, Amelia Kirby26, Hailey Pinz26, Hannah Bombei6, Sonal Mahida2, Julie S Cohen2, Ali Fatemi2, Hilary J Vernon2, Rebecca McClellan2, Leah R Fleming27, Brittney Knyszek27, Michelle Steinraths28, Cruz Velasco Gonzalez29, Anita E Beck21,22, Katie L Golden-Grant22, Alena Egense3, Aditi Parikh30,31,32, Chantalle Raimondi33, Brad Angle33, William Allen34, Suzanna Schott34, Adi Algrabli35, Nathaniel H Robin36, Joseph W Ray20, David B Everman37, Michael J Gambello38, Wendy K Chung39.
Abstract
SATB2-associated syndrome (SAS) is an autosomal dominant disorder characterized by significant neurodevelopmental disabilities with limited to absent speech, behavioral issues, and craniofacial anomalies. Previous studies have largely been restricted to case reports and small series without in-depth phenotypic characterization or genotype-phenotype correlations. Seventy two study participants were identified as part of the SAS clinical registry. Individuals with a molecularly confirmed diagnosis of SAS were referred after clinical diagnostic testing. In this series we present the most comprehensive phenotypic and genotypic characterization of SAS to date, including prevalence of each clinical feature, neurodevelopmental milestones, and when available, patient management. We confirm that the most distinctive features are neurodevelopmental delay with invariably severely limited speech, abnormalities of the palate (cleft or high-arched), dental anomalies (crowding, macrodontia, abnormal shape), and behavioral issues with or without bone or brain anomalies. This comprehensive clinical characterization will help clinicians with the diagnosis, counseling and management of SAS and help provide families with anticipatory guidance.Entities:
Keywords: 2q33.1; SATB; SATB2-associated syndrome; facial recognition technology; genotype-phenotype correlation; natural history
Mesh:
Substances:
Year: 2018 PMID: 29436146 DOI: 10.1002/ajmg.a.38630
Source DB: PubMed Journal: Am J Med Genet A ISSN: 1552-4825 Impact factor: 2.802